TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Cell-Free DNA (cfDNA) Testing Market Research Report 2023

Global Cell-Free DNA (cfDNA) Testing Market Research Report 2023

  • Category:Life Sciences
  • Published on : 10 February 2023
  • Pages :93
  • Formats:
  • Report Code:SMR-7558783

Market Analysis and Insights: Global CellFree DNA cfDNA Testing Market

The global CellFree DNA cfDNA Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global CellFree DNA cfDNA Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global CellFree DNA cfDNA Testing market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global CellFree DNA cfDNA Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global CellFree DNA cfDNA Testing market.

Global CellFree DNA cfDNA Testing Scope and Market Size

Cell-Free DNA (cfDNA) Testing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Cell-Free DNA (cfDNA) Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2032.
Segment by Type
Donor-Derived Cell-Free DNA (DdcfDNA)
Circulating Cell-Free Tumor DNA (CtDNA)
Cell-Free Fetal DNA (NIPT)
Segment by Application
Hospital
Ambulatory Surgical Centers
Cancer Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Agilent Technology
Allenex
Biocept
Biodesix
CareDx
Guardant Health
Illumania
Invited
Natera
Quest Diagnostics
Roche Holdings
Sequenom
Trovagene

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes CellFree DNA cfDNA Testing product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of CellFree DNA cfDNA Testing, with price, sales, revenue, and global market share of CellFree DNA cfDNA Testing from 2019 to 2022.

Chapter 3, the CellFree DNA cfDNA Testing competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the CellFree DNA cfDNA Testing breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the CellFree DNA cfDNA Testing market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of CellFree DNA cfDNA Testing.

Chapter 13, 14, and 15, to describe CellFree DNA cfDNA Testing sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 CellFree DNA cfDNA Testing Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

TABLE OF CONTENTS

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2032
1.2.2 Donor-Derived Cell-Free DNA (DdcfDNA)
1.2.3 Circulating Cell-Free Tumor DNA (CtDNA)
1.2.4 Cell-Free Fetal DNA (NIPT)
1.3 Market by Application
1.3.1 Global Cell-Free DNA (cfDNA) Testing Market Share by Application: 2018 VS 2022 VS 2032
1.3.2 Hospital
1.3.3 Ambulatory Surgical Centers
1.3.4 Cancer Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cell-Free DNA (cfDNA) Testing Market Perspective (2018-2032)
2.2 Cell-Free DNA (cfDNA) Testing Growth Trends by Region
2.2.1 Cell-Free DNA (cfDNA) Testing Market Size by Region: 2018 VS 2022 VS 2032
2.2.2 Cell-Free DNA (cfDNA) Testing Historic Market Size by Region (2018-2023)
2.2.3 Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Region (2023-2032)
2.3 Cell-Free DNA (cfDNA) Testing Market Dynamics
2.3.1 Cell-Free DNA (cfDNA) Testing Industry Trends
2.3.2 Cell-Free DNA (cfDNA) Testing Market Drivers
2.3.3 Cell-Free DNA (cfDNA) Testing Market Challenges
2.3.4 Cell-Free DNA (cfDNA) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell-Free DNA (cfDNA) Testing Players by Revenue
3.1.1 Global Top Cell-Free DNA (cfDNA) Testing Players by Revenue (2018-2023)
3.1.2 Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Players (2018-2023)
3.2 Global Cell-Free DNA (cfDNA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell-Free DNA (cfDNA) Testing Revenue
3.4 Global Cell-Free DNA (cfDNA) Testing Market Concentration Ratio
3.4.1 Global Cell-Free DNA (cfDNA) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell-Free DNA (cfDNA) Testing Revenue in 2022
3.5 Cell-Free DNA (cfDNA) Testing Key Players Head office and Area Served
3.6 Key Players Cell-Free DNA (cfDNA) Testing Product Solution and Service
3.7 Date of Enter into Cell-Free DNA (cfDNA) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell-Free DNA (cfDNA) Testing Breakdown Data by Type
4.1 Global Cell-Free DNA (cfDNA) Testing Historic Market Size by Type (2018-2023)
4.2 Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Type (2023-2032)
5 Cell-Free DNA (cfDNA) Testing Breakdown Data by Application
5.1 Global Cell-Free DNA (cfDNA) Testing Historic Market Size by Application (2018-2023)
5.2 Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Cell-Free DNA (cfDNA) Testing Market Size (2018-2032)
6.2 North America Cell-Free DNA (cfDNA) Testing Market Size by Country (2018-2023)
6.3 North America Cell-Free DNA (cfDNA) Testing Market Size by Country (2023-2032)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Cell-Free DNA (cfDNA) Testing Market Size (2018-2032)
7.2 Europe Cell-Free DNA (cfDNA) Testing Market Size by Country (2018-2023)
7.3 Europe Cell-Free DNA (cfDNA) Testing Market Size by Country (2023-2032)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size (2018-2032)
8.2 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Country (2018-2023)
8.3 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Country (2023-2032)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Cell-Free DNA (cfDNA) Testing Market Size (2018-2032)
9.2 Latin America Cell-Free DNA (cfDNA) Testing Market Size by Country (2018-2023)
9.3 Latin America Cell-Free DNA (cfDNA) Testing Market Size by Country (2023-2032)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size (2018-2032)
10.2 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Country (2018-2023)
10.3 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Country (2023-2032)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Agilent Technology
11.1.1 Agilent Technology Company Detail
11.1.2 Agilent Technology Business Overview
11.1.3 Agilent Technology Cell-Free DNA (cfDNA) Testing Introduction
11.1.4 Agilent Technology Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
11.1.5 Agilent Technology Recent Development
11.2 Allenex
11.2.1 Allenex Company Detail
11.2.2 Allenex Business Overview
11.2.3 Allenex Cell-Free DNA (cfDNA) Testing Introduction
11.2.4 Allenex Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
11.2.5 Allenex Recent Development
11.3 Biocept
11.3.1 Biocept Company Detail
11.3.2 Biocept Business Overview
11.3.3 Biocept Cell-Free DNA (cfDNA) Testing Introduction
11.3.4 Biocept Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
11.3.5 Biocept Recent Development
11.4 Biodesix
11.4.1 Biodesix Company Detail
11.4.2 Biodesix Business Overview
11.4.3 Biodesix Cell-Free DNA (cfDNA) Testing Introduction
11.4.4 Biodesix Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
11.4.5 Biodesix Recent Development
11.5 CareDx
11.5.1 CareDx Company Detail
11.5.2 CareDx Business Overview
11.5.3 CareDx Cell-Free DNA (cfDNA) Testing Introduction
11.5.4 CareDx Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
11.5.5 CareDx Recent Development
11.6 Guardant Health
11.6.1 Guardant Health Company Detail
11.6.2 Guardant Health Business Overview
11.6.3 Guardant Health Cell-Free DNA (cfDNA) Testing Introduction
11.6.4 Guardant Health Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
11.6.5 Guardant Health Recent Development
11.7 Illumania
11.7.1 Illumania Company Detail
11.7.2 Illumania Business Overview
11.7.3 Illumania Cell-Free DNA (cfDNA) Testing Introduction
11.7.4 Illumania Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
11.7.5 Illumania Recent Development
11.8 Invited
11.8.1 Invited Company Detail
11.8.2 Invited Business Overview
11.8.3 Invited Cell-Free DNA (cfDNA) Testing Introduction
11.8.4 Invited Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
11.8.5 Invited Recent Development
11.9 Natera
11.9.1 Natera Company Detail
11.9.2 Natera Business Overview
11.9.3 Natera Cell-Free DNA (cfDNA) Testing Introduction
11.9.4 Natera Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
11.9.5 Natera Recent Development
11.10 Quest Diagnostics
11.10.1 Quest Diagnostics Company Detail
11.10.2 Quest Diagnostics Business Overview
11.10.3 Quest Diagnostics Cell-Free DNA (cfDNA) Testing Introduction
11.10.4 Quest Diagnostics Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
11.10.5 Quest Diagnostics Recent Development
11.11 Roche Holdings
11.11.1 Roche Holdings Company Detail
11.11.2 Roche Holdings Business Overview
11.11.3 Roche Holdings Cell-Free DNA (cfDNA) Testing Introduction
11.11.4 Roche Holdings Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
11.11.5 Roche Holdings Recent Development
11.12 Sequenom
11.12.1 Sequenom Company Detail
11.12.2 Sequenom Business Overview
11.12.3 Sequenom Cell-Free DNA (cfDNA) Testing Introduction
11.12.4 Sequenom Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
11.12.5 Sequenom Recent Development
11.13 Trovagene
11.13.1 Trovagene Company Detail
11.13.2 Trovagene Business Overview
11.13.3 Trovagene Cell-Free DNA (cfDNA) Testing Introduction
11.13.4 Trovagene Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
11.13.5 Trovagene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2032
Table 2. Key Players of Donor-Derived Cell-Free DNA (DdcfDNA)
Table 3. Key Players of Circulating Cell-Free Tumor DNA (CtDNA)
Table 4. Key Players of Cell-Free Fetal DNA (NIPT)
Table 5. Global Cell-Free DNA (cfDNA) Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2032
Table 6. Global Cell-Free DNA (cfDNA) Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2032
Table 7. Global Cell-Free DNA (cfDNA) Testing Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Cell-Free DNA (cfDNA) Testing Market Share by Region (2018-2023)
Table 9. Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Region (2023-2032) & (US$ Million)
Table 10. Global Cell-Free DNA (cfDNA) Testing Market Share by Region (2023-2032)
Table 11. Cell-Free DNA (cfDNA) Testing Market Trends
Table 12. Cell-Free DNA (cfDNA) Testing Market Drivers
Table 13. Cell-Free DNA (cfDNA) Testing Market Challenges
Table 14. Cell-Free DNA (cfDNA) Testing Market Restraints
Table 15. Global Cell-Free DNA (cfDNA) Testing Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Cell-Free DNA (cfDNA) Testing Market Share by Players (2018-2023)
Table 17. Global Top Cell-Free DNA (cfDNA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Free DNA (cfDNA) Testing as of 2022)
Table 18. Ranking of Global Top Cell-Free DNA (cfDNA) Testing Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Cell-Free DNA (cfDNA) Testing Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cell-Free DNA (cfDNA) Testing Product Solution and Service
Table 22. Date of Enter into Cell-Free DNA (cfDNA) Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cell-Free DNA (cfDNA) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Type (2018-2023)
Table 26. Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Type (2023-2032) & (US$ Million)
Table 27. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Type (2023-2032)
Table 28. Global Cell-Free DNA (cfDNA) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Application (2018-2023)
Table 30. Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Application (2023-2032) & (US$ Million)
Table 31. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Application (2023-2032)
Table 32. North America Cell-Free DNA (cfDNA) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Cell-Free DNA (cfDNA) Testing Market Size by Country (2023-2032) & (US$ Million)
Table 34. Europe Cell-Free DNA (cfDNA) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Cell-Free DNA (cfDNA) Testing Market Size by Country (2023-2032) & (US$ Million)
Table 36. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Region (2018-2023) & (US$ Million)
Table 37. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Region (2023-2032) & (US$ Million)
Table 38. Latin America Cell-Free DNA (cfDNA) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 39. Latin America Cell-Free DNA (cfDNA) Testing Market Size by Country (2023-2032) & (US$ Million)
Table 40. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 41. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Country (2023-2032) & (US$ Million)
Table 42. Agilent Technology Company Detail
Table 43. Agilent Technology Business Overview
Table 44. Agilent Technology Cell-Free DNA (cfDNA) Testing Product
Table 45. Agilent Technology Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023) & (US$ Million)
Table 46. Agilent Technology Recent Development
Table 47. Allenex Company Detail
Table 48. Allenex Business Overview
Table 49. Allenex Cell-Free DNA (cfDNA) Testing Product
Table 50. Allenex Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023) & (US$ Million)
Table 51. Allenex Recent Development
Table 52. Biocept Company Detail
Table 53. Biocept Business Overview
Table 54. Biocept Cell-Free DNA (cfDNA) Testing Product
Table 55. Biocept Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023) & (US$ Million)
Table 56. Biocept Recent Development
Table 57. Biodesix Company Detail
Table 58. Biodesix Business Overview
Table 59. Biodesix Cell-Free DNA (cfDNA) Testing Product
Table 60. Biodesix Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023) & (US$ Million)
Table 61. Biodesix Recent Development
Table 62. CareDx Company Detail
Table 63. CareDx Business Overview
Table 64. CareDx Cell-Free DNA (cfDNA) Testing Product
Table 65. CareDx Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023) & (US$ Million)
Table 66. CareDx Recent Development
Table 67. Guardant Health Company Detail
Table 68. Guardant Health Business Overview
Table 69. Guardant Health Cell-Free DNA (cfDNA) Testing Product
Table 70. Guardant Health Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023) & (US$ Million)
Table 71. Guardant Health Recent Development
Table 72. Illumania Company Detail
Table 73. Illumania Business Overview
Table 74. Illumania Cell-Free DNA (cfDNA) Testing Product
Table 75. Illumania Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023) & (US$ Million)
Table 76. Illumania Recent Development
Table 77. Invited Company Detail
Table 78. Invited Business Overview
Table 79. Invited Cell-Free DNA (cfDNA) Testing Product
Table 80. Invited Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023) & (US$ Million)
Table 81. Invited Recent Development
Table 82. Natera Company Detail
Table 83. Natera Business Overview
Table 84. Natera Cell-Free DNA (cfDNA) Testing Product
Table 85. Natera Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023) & (US$ Million)
Table 86. Natera Recent Development
Table 87. Quest Diagnostics Company Detail
Table 88. Quest Diagnostics Business Overview
Table 89. Quest Diagnostics Cell-Free DNA (cfDNA) Testing Product
Table 90. Quest Diagnostics Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023) & (US$ Million)
Table 91. Quest Diagnostics Recent Development
Table 92. Roche Holdings Company Detail
Table 93. Roche Holdings Business Overview
Table 94. Roche Holdings Cell-Free DNA (cfDNA) TestingProduct
Table 95. Roche Holdings Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023) & (US$ Million)
Table 96. Roche Holdings Recent Development
Table 97. Sequenom Company Detail
Table 98. Sequenom Business Overview
Table 99. Sequenom Cell-Free DNA (cfDNA) TestingProduct
Table 100. Sequenom Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023) & (US$ Million)
Table 101. Sequenom Recent Development
Table 102. Trovagene Company Detail
Table 103. Trovagene Business Overview
Table 104. Trovagene Cell-Free DNA (cfDNA) TestingProduct
Table 105. Trovagene Revenue in Cell-Free DNA (cfDNA) Testing Business (2018-2023) & (US$ Million)
Table 106. Trovagene Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell-Free DNA (cfDNA) Testing Market Share by Type: 2022 VS 2032
Figure 2. Donor-Derived Cell-Free DNA (DdcfDNA) Features
Figure 3. Circulating Cell-Free Tumor DNA (CtDNA) Features
Figure 4. Cell-Free Fetal DNA (NIPT) Features
Figure 5. Global Cell-Free DNA (cfDNA) Testing Market Share by Application in 2022 & 2032
Figure 6. Hospital Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Cancer Research Institutes Case Studies
Figure 9. Cell-Free DNA (cfDNA) Testing Report Years Considered
Figure 10. Global Cell-Free DNA (cfDNA) Testing Market Size (US$ Million), Year-over-Year: 2018-2032
Figure 11. Global Cell-Free DNA (cfDNA) Testing Market Size, (US$ Million), 2018 VS 2022 VS 2032
Figure 12. Global Cell-Free DNA (cfDNA) Testing Market Share by Region: 2022 VS 2032
Figure 13. Global Cell-Free DNA (cfDNA) Testing Market Share by Players in 2022
Figure 14. Global Top Cell-Free DNA (cfDNA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Free DNA (cfDNA) Testing as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Cell-Free DNA (cfDNA) Testing Revenue in 2022
Figure 16. North America Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 17. North America Cell-Free DNA (cfDNA) Testing Market Share by Country (2018-2032)
Figure 18. United States Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 19. Canada Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 20. Europe Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 21. Europe Cell-Free DNA (cfDNA) Testing Market Share by Country (2018-2032)
Figure 22. Germany Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 23. France Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 24. U.K. Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 25. Italy Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 26. Russia Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 27. Nordic Countries Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 28. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 29. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Share by Region (2018-2032)
Figure 30. China Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 31. Japan Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 32. South Korea Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 33. Southeast Asia Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 34. India Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 35. Australia Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 36. Latin America Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 37. Latin America Cell-Free DNA (cfDNA) Testing Market Share by Country (2018-2032)
Figure 38. Mexico Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 39. Brazil Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 40. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 41. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Share by Country (2018-2032)
Figure 42. Turkey Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 43. Saudi Arabia Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 44. Agilent Technology Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
Figure 45. Allenex Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
Figure 46. Biocept Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
Figure 47. Biodesix Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
Figure 48. CareDx Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
Figure 49. Guardant Health Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
Figure 50. Illumania Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
Figure 51. Invited Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
Figure 52. Natera Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
Figure 53. Quest Diagnostics Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
Figure 54. Roche Holdings Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
Figure 55. Sequenom Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
Figure 56. Trovagene Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

Offer REPORT BUYING OPTIONS

USD GBP EURO YEN Single User Price
USD GBP EURO YEN Multi User Price
USD GBP EURO YEN Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount